Skip to main content
Yardeni Research
Menu
Theme
Sign In
S&P 500754.37-0.36%
Dow 30523.15+0.13%
Nasdaq679.89-1.20%
VIX17.94+2.46%
10-Yr Yield5.10%+2.41%
2-Yr Yield4.86%+2.75%
2s/10s Spread+0.24%
Gold$3,901+0.53%
Silver$49.00+0.54%
USD Index29.50+0.27%
EUR/USD1.1026+0.04%
USD/JPY159.79+0.12%
Bitcoin$65,330-0.03%
S&P 500754.37-0.36%
Dow 30523.15+0.13%
Nasdaq679.89-1.20%
VIX17.94+2.46%
10-Yr Yield5.10%+2.41%
2-Yr Yield4.86%+2.75%
2s/10s Spread+0.24%
Gold$3,901+0.53%
Silver$49.00+0.54%
USD Index29.50+0.27%
EUR/USD1.1026+0.04%
USD/JPY159.79+0.12%
Bitcoin$65,330-0.03%
S&P 500754.37-0.36%
Dow 30523.15+0.13%
Nasdaq679.89-1.20%
VIX17.94+2.46%
10-Yr Yield5.10%+2.41%
2-Yr Yield4.86%+2.75%
2s/10s Spread+0.24%
Gold$3,901+0.53%
Silver$49.00+0.54%
USD Index29.50+0.27%
EUR/USD1.1026+0.04%
USD/JPY159.79+0.12%
Bitcoin$65,330-0.03%

Independent Financial Research & Analysis

Since 2007

Daily briefings, 7,700+ real-time charts, and macro insights from Dr. Ed Yardeni and his research team.

Yardeni Research chart search interface showing real-time market data visualizations
Morning Briefings and QuickTakes on mobile devices showing market analysis

Research

Latest Research

Recent insights from our research team

Morning Briefing

Slicing & Dicing The Fed’s Inflation Problem

When inflation is driven by supply shocks, there’s less the Fed can do about it. But today’s inflation is not caused totally by supply shocks, won’t simply snap back to the Fed’s target rate when the shocks dispel, and can be influenced by monetary policy. Today, Elias and Ed share their belief that the inflationary environment changed structurally in the years after the pandemic, in ways that make it more difficult for the Fed to achieve its inflation target. Without being able to influence structurally higher goods inflation as much, the Fed will have to lower services inflation by raising the federal funds rate. We think 50 more basis points will do it. Lower oil prices should help to moderate inflation in the near term; productivity should do so in the long run. … Also: Dr. Ed reviews “The Diplomat” (+).

QuickTakes

GLOBAL MARKETS CALL: Central Banks Are Tightening

The global AI trade should make a nice comeback now that the latest issue of The Economist sees the bottom falling out of it: The weekly financial magazine, famous for its contrarian cover stories, also recently picked the top in global bond yields when it ran a cover story titled "Will bonds blow up?" in the October 10-16 issue. Then again, bond yields rose worldwide last week. Central bankers sounded more hawkish, and inflation remains sticky. Bond investors expect more monetary policy tightening ahead. Stock markets barely moved last week. Global profits are booming, yet valuations keep falling, almost everywhere. We think they are at or near a bottom. Gold continues to falter, and China’s problems are depressing stock prices there. Here’s more: I. Stock Market Derby The US has held its ground in November. The US MSCI’s share of the All Country World MSCI’s market capitalization is 65.3% (chart). The Europe MSCI’s share is 13.5%. The Emerging Markets (EM) MSCI’s share has slipped to 11.0%. The US MSCI’s share of global forward earnings hasn’t kept pace. It has edged down to 54.1% from 54.3% two weeks ago, well below its market-cap share (chart). The EM MSCI’s earnings share has climbed to 20.6% even as its market-cap share has fallen. Investors are pricing the South Korea and Taiwan MSCIs at historically low multiples. The Eurozone and UK ETFs have gained on the US ETF in recent months (chart). The All Country World ex-US ETF continues to track the US ETF closely. The US has pulled back less from its recent high. Global stock markets have gone mostly sideways this month (chart). The All Country World ETF is flat mtd. The US is in the middle of the pack, down 0.2%. Turkey leads with a 9.0% gain. South Korea (-6.6%) and Taiwan (-3.7%) remain at the bottom of the performance list. II. Stock Market Earnings & Valuation US and overseas forward earnings continue to climb together to record highs (chart). The two have tracked each other closely since 2024. Global profits are booming. The US MSCI’s forward profit margin has risen to a record high of 16.9% (chart). The Canada MSCI’s is even higher at 17.1%. The EM MSCI’s forward profit margin has jumped to 13.9%. And the All Country World ex-US MSCI’s is up to 12.9%. Valuations have been falling everywhere. The US MSCI’s forward P/E is down to 18.5 (chart). The EMU MSCI’s is 14.3, the Japan MSCI’s is 14.1, and the UK MSCI’s is 12.0. The EM MSCI trades at a forward P/E of just 8.4. We think global valuations are at or near bottoming. Further downside looks limited to us. III. Bonds Bond yields rose this week on hawkish central bank commentary and stubborn inflation (chart). The 10-year US Treasury yield jumped to 5.16% from 4.86% a week earlier. The UK’s 10-year government bond yield of 5.34% remains the highest in the group. The spread between French and German 10-year yields widened to 154.2bps (chart). That’s below its October high. France’s increase this week was much bigger than those of other European countries. Two-year government bond yields are well above central bank policy rates (chart). These yields are pricing in continued global tightening for the foreseeable future. IV. Gold Gold’s latest correction resembles its pullbacks in the mid-1970s and during the Great Financial Crisis (chart). Those corrections occurred during or right after recessions. Gold has had a disappointing year so far. The nearby futures price broke below support at $4,000 per ounce and is now $3,879.70 (chart). That's well below its 200-day moving average. We don’t see what might lift the gold price in the near term. We are pushing back our $5,000 target to the end of 2027. The main bullish driver is central bank gold buying. The main bearish factor is rising interest rates. V. China The China MSCI stock price index has been falling since late last year (chart). Forward earnings has been rising slowly, while the forward P/E has declined more quickly to about 10.0. China’s property bust keeps getting worse. The Shenzhen Real Estate Stock Price Index has fallen to 897.61, further below the 1,000 support that had held since 2012 (chart). On October 18, we wrote that we would worry if it broke below that level. We remain concerned. Exports continue to carry the economy, while domestic consumption remains very weak. Chinese tech stocks took another hit last week. The China Technology ETF (CQQQ) fell 4.4% (chart). Nvidia CEO Jensen Huang resigned on November 12 amid reports linking him to chip shipments to China. Alibaba stock fell 14%, and Baidu stock fell 4.6% last week as the news hit. Investors fear Washington will further tighten restrictions on China’s access to Nvidia’s processors. We continue to favor the EM ex-China MSCI over the China MSCI.

QuickTakes

US SECTORS CALL: Financials, Health Care & Consumer Staples

Stocks bounced back last week after the prior week’s AI selloff. The S&P 500 rose 2.5% and is up 10.5% ytd. The chip trade rebounded, but leadership changed hands. Nvidia’s board opened an investigation into allegations against CEO Jensen Huang, who resigned on Thursday. CFO Colette Kress is interim CEO. Investors moved into the stocks of Nvidia’s rivals. AMD rose 19% for the week, and Broadcom rose 18% as Nvidia fell 13%. Health Care and Financials have outperformed since the market’s March 30 low. Health Care is up 31.1% and Financials 21.1%, both ahead of the S&P 500’s 19.2% (chart). Staples has lagged, up just 12.3% over the same period, even though it's up 20.2% ytd. Here’s more on Financials, Health Care, and Consumer Staples: (1) Financials. The IPO window is wide open. SpaceX raised $75 billion in June, the largest IPO ever, and its shares rose 19% on the first day. Anthropic’s shares are expected to begin trading on Thursday at $70-$78 each, implying a fully diluted valuation of $1.26 trillion to $1.40 trillion. Its S-1 filing affirmed that AI customers will pay up for compute. In Q2, Anthropic earned $2.08 of revenue per dollar of compute and infrastructure expense, up fivefold from $0.40 in Q1-2025 (in Q3, however, the figure dipped to $1.72, as the company bought costlier short-term capacity to meet demand). Big AI listings bring fees for underwriters, trading desks, and the asset managers who buy the deals (chart). Analysts have expected a strong year for capital markets. They collectively forecast Investment Banking & Brokerage revenues to grow 21.1% this year, up from 7.4% in December (chart). Earnings are forecast to grow 30.9%. Yet the industry’s forward P/E has fallen to 13.6 from 19.1 earlier this year. Investors are not paying for the deal boom. The Financials sector’s forward profit margin is a record 22.1%, and the profitability is broad-based. Forward profit margins are at or near record highs across the sector’s biggest industries: Asset Management & Custody Banks (28.6%), Regional Banks (28.5%), Investment Banking (28.1%), and Diversified Banks (27.8%) (chart). The Financials sector’s forward P/E has fallen to 15.2 from 16.4 at year-end 2025, while its forward earnings is up 14.0% ytd. The sector has been getting cheaper as it gets more profitable. We retain our overweight rating on Financials. (2) Health Care. Health Care has been the best-performing sector since March 30. It is up 21.8% ytd. Forward earnings is up 11.5% ytd, and the forward P/E is up 9.4% (chart). It trades at 19.8 times forward earnings, a premium to the S&P 500’s 18.2. Health Care’s profitability has been turning up. The sector’s forward profit margin has risen to 8.7% from a low of 7.9% in January (chart). Within the sector, the Biotechnology industry’s forward profit margin is at 33.4% and Pharmaceuticals’ is at 31.1%; both have been climbing. The Pharmaceuticals industry accounts for 37% of the sector’s market capitalization. Analysts collectively expect Pharma earnings to fall 5.9% this year, then jump 29.6% in 2027 (chart). But they’ve more than doubled their revenue sights this year: The consensus 2026 revenue estimate implies growth of 9.9%, up from 4.0% in December. The rebound rests on sales, not just a low base from which the growth is measured. AI should speed progress up in the medical world. In Anthropic’s IPO roadshow video on Tuesday, CEO Dario Amodei claimed that AI can compress 50 to 100 years of medical research into five to ten. We think the benefits to drug discovery could be huge. Investors already see it. Moderna is up 623.8% ytd following the success of its personalized cancer vaccine, designed with the help of machine learning. Clinical trials and approvals still take years, so the payoff will build over time. Pharma’s 2027 rebound doesn’t depend on it. We continue to recommend overweighting Health Care. (3) Consumer Staples. Staples is one of only three sectors that got more expensive this year. Its forward P/E has risen to 23.9 from 20.8 at the end of 2025. Over the same period, the S&P 500’s P/E fell to 18.2 from 22.2, and IT’s fell to 17.2 from 26.5 (chart). Only Real Estate and Consumer Discretionary trade at higher multiples. Forward earnings is up just 4.6% ytd, while the forward P/E is up 13.5% (chart). Almost all of that re-rating came after late September, when investors fled the AI trade for defensive stocks. Profitability has not improved. The sector’s forward profit margin is 7.1%, below its 2021 peak of 7.7% (chart). Analysts have cut their 2027 earnings growth estimate to 5.6% from 7.3% in August. Investors are paying 23.9 times forward earnings for single-digit-percentage growth. Walmart and Target are set to report quarterly earnings next week. The Merchandise Retail industry trades at 36.4 times forward earnings, its highest forward P/E since earlier this year (chart). Investors pay up for Consumer Staples stocks when they fear an economic slowdown. But the labor market is picking up, and consumers are spending. That makes the valuation premium characteristic of defensive sectors hard to justify. We retain our underweight rating on Consumer Staples.

Charts

Find Any Chart in Seconds

Search across 7,794+ real-time charts with instant visual previews

Popular:
unemployment
inflation
S&P 500
GDP
interest rates
S&P 500 HEALTH CARE SECTOR & INDUSTRIES: ANNUAL EARNING GROWTH FORECAST

S&P 500 HEALTH CARE SECTOR & INDUSTRIES: ANNUAL EARNING GROWTH FORECAST

BNY MELLON: STOCK PRICE (BK)

BNY MELLON: STOCK PRICE (BK)

DELL TECHNOLOGIES: FORWARD OPERATING EARNINGS PER SHARE

DELL TECHNOLOGIES: FORWARD OPERATING EARNINGS PER SHARE

LOWE'S: FORWARD LTEG, STRG & STEG

LOWE'S: FORWARD LTEG, STRG & STEG

Sample charts from our collection of 7,794+ visualizations

Try Yardeni Research free for four weeks.

Full access to everything we publish. No credit card, no obligation.

Daily Morning Briefings7,700+ Real-Time ChartsSame-Day QuickTakes